Table 3: The
age-stratified percentage of DS subjects living at Institution A with disease.
|
Diagnosed
disease |
Total |
Male |
Female |
||||||||||||||||||||
|
Under the age 40
n = 8 |
40s n = 5 |
50s n = 18 |
60s n = 5 |
Male total n = 36 |
under the age 40 n = 2 |
40s n = 4 |
50s n = 9 |
60s n = 8 |
Female total n = 23 |
|
|||||||||||||
|
Dyslipidemia |
36 |
(61.0%) |
3 |
(37.5%) |
3 |
(60.0%) |
11 |
(61.1%) |
3 |
(60.0%) |
20 |
(55.6%) |
0 |
(0.0%) |
3 |
(75.0%) |
6 |
(66.7%) |
7 |
(87.5%) |
16 |
(69.6%) |
|
|
Ringworm of the nails and/or skin |
35 |
(59.3%) |
4 |
(50.0%) |
4 |
(80.0%) |
11 |
(61.1%) |
4 |
(80.0%) |
23 |
(63.9%) |
1 |
(50.0%) |
1 |
(25.0%) |
4 |
(44.4%) |
6 |
(75.0%) |
12 |
(52.2%) |
|
|
Hypothyroidism |
18 |
(30.5%) |
1 |
(12.5%) |
0 |
(0.0%) |
5 |
(27.8%) |
3 |
(60.0%) |
9 |
(25.0%) |
1 |
(50.0%) |
2 |
(50.0%) |
2 |
(22.2%) |
4 |
(50.0%) |
9 |
(39.1%) |
|
|
Hyperuricemia |
15 |
(25.4%) |
3 |
(37.5%) |
2 |
(40.0%) |
2 |
(11.1%) |
1 |
(20.0%) |
8 |
(22.2%) |
0 |
(0.0%) |
2 |
(50.0%) |
2 |
(22.2%) |
3 |
(37.5%) |
7 |
(30.4%) |
|
|
Cataracts |
14 |
(23.7%) |
0 |
(0.0%) |
0 |
(0.0%) |
6 |
(33.3%) |
2 |
(40.0%) |
8 |
(22.2%) |
0 |
(0.0%) |
0 |
(0.0%) |
2 |
(22.2%) |
4 |
(50.0%) |
6 |
(26.1%) |
|
|
Neurogenic bladder |
11 |
(18.6%) |
1 |
(12.5%) |
0 |
(0.0%) |
2 |
(11.1%) |
1 |
(20.0%) |
4 |
(11.1%) |
0 |
(0.0%) |
1 |
(25.0%) |
5 |
(55.6%) |
1 |
(12.5%) |
7 |
(30.4%) |
|
|
Heart disease |
10 |
(16.9%) |
2 |
(25.0%) |
2 |
(40.0%) |
1 |
(5.6%) |
1 |
(20.0%) |
6 |
(16.7%) |
1 |
(50.0%) |
2 |
(50.0%) |
1 |
(11.1%) |
0 |
(0.0%) |
4 |
(17.4%) |
|
|
Dementia |
10 |
(16.9%) |
0 |
(0.0%) |
0 |
(0.0%) |
3 |
(16.7%) |
3 |
(60.0%) |
6 |
(16.7%) |
0 |
(0.0%) |
0 |
(0.0%) |
1 |
(11.1%) |
3 |
(37.5%) |
4 |
(17.4%) |
|
|
Epilepsy |
10 |
(16.9%) |
0 |
(0.0%) |
0 |
(0.0%) |
3 |
(16.7%) |
2 |
(40.0%) |
5 |
(13.9%) |
0 |
(0.0%) |
1 |
(25.0%) |
0 |
(0.0%) |
4 |
(50.0%) |
5 |
(21.7%) |
|
|
Obesity |
9 |
(15.3%) |
1 |
(12.5%) |
1 |
(20.0%) |
3 |
(16.7%) |
0 |
(0.0%) |
5 |
(13.9%) |
0 |
(0.0%) |
2 |
(50.0%) |
0 |
(0.0%) |
2 |
(25.0%) |
4 |
(17.4%) |
|
|
Hypertention |
7 |
(11.9%) |
0 |
(0.0%) |
0 |
(0.0%) |
4 |
(22.2%) |
0 |
(0.0%) |
4 |
(11.1%) |
0 |
(0.0%) |
0 |
(0.0%) |
2 |
(22.2%) |
1 |
(12.5%) |
3 |
(13.0%) |
|
|
Peripheral circulatory failure |
6 |
(10.2%) |
0 |
(0.0%) |
1 |
(20.0%) |
2 |
(11.1%) |
1 |
(20.0%) |
4 |
(11.1%) |
0 |
(0.0%) |
1 |
(25.0%) |
0 |
(0.0%) |
1 |
(12.5%) |
2 |
(8.7%) |
|
|
Diabetesmellitus |
5 |
(8.5%) |
1 |
(12.5%) |
1 |
(20.0%) |
0 |
(0.0%) |
0 |
(0.0%) |
2 |
(5.6%) |
0 |
0.00% |
1 |
(25.0%) |
0 |
(0.0%) |
2 |
(25.0%) |
3 |
(13.0%) |
|
|
Sleep apnea attacks |
2 |
(3.4%) |
0 |
(0.0%) |
0 |
(0.0%) |
0 |
(0.0%) |
1 |
(20.0%) |
1 |
(2.8%) |
0 |
(0.0%) |
0 |
(0.0%) |
0 |
(0.0%) |
1 |
(12.5%) |
1 |
(4.3%) |
|
|
Testicular tumor |
2 |
(5.6%) |
0 |
(0.0%) |
0 |
(0.0%) |
0 |
(0.0%) |
2 |
(40.0%) |
2 |
(5.6%) |
- |
- |
- |
- |
- |
|
|||||